Nanobiotix
NBTX
10 hedge funds and large institutions have $66.9M invested in Nanobiotix in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0.04% less ownership
Funds ownership: 13.98% → 13.94% (-0.04%)
9% less capital invested
Capital invested by funds: $73.2M → $66.9M (-$6.31M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$163K |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$70.7K |
NBTX Hedge Fund Activity: Q2 2021 in Review
10 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q2 2021, worth a combined $66.9M — down 8.6% from $73.2M a quarter earlier.
Fund positioning in NBTX was balanced in Q2 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.36K. The largest seller was UBS Group, cutting an estimated $163K.
- 10 institutional investors held Nanobiotix (NBTX) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $66.9M of Nanobiotix stock for Q2 2021, down 8.6% quarter-over-quarter.
- 0 funds opened new Nanobiotix positions in Q2 2021 and 0 closed out.
- The largest Nanobiotix buyer in Q2 2021 was Millennium Management, an estimated $2.36K added.
- The largest Nanobiotix seller in Q2 2021 was UBS Group, an estimated $163K sold.
Based on aggregated 13F filings for Q2 2021.